The Fort Worth Press - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.672505
AFN 64.999617
ALL 81.873378
AMD 378.439629
ANG 1.79008
AOA 917.000017
ARS 1444.993898
AUD 1.424623
AWG 1.8025
AZN 1.698328
BAM 1.658498
BBD 2.01317
BDT 122.152876
BGN 1.67937
BHD 0.37697
BIF 2962.5
BMD 1
BND 1.270543
BOB 6.906845
BRL 5.239098
BSD 0.999546
BTN 90.307481
BWP 13.806116
BYN 2.86383
BYR 19600
BZD 2.010235
CAD 1.36445
CDF 2199.999975
CHF 0.776105
CLF 0.021794
CLP 860.539972
CNY 6.938197
CNH 6.93502
COP 3646.93
CRC 496.408795
CUC 1
CUP 26.5
CVE 93.750278
CZK 20.60345
DJF 177.720253
DKK 6.32319
DOP 63.000254
DZD 129.900254
EGP 47.009197
ERN 15
ETB 155.042675
EUR 0.846625
FJD 2.198801
FKP 0.732491
GBP 0.730199
GEL 2.695012
GGP 0.732491
GHS 10.944975
GIP 0.732491
GMD 73.000094
GNF 8753.999774
GTQ 7.666672
GYD 209.120397
HKD 7.813115
HNL 26.408086
HRK 6.376701
HTG 131.107644
HUF 322.478502
IDR 16766
ILS 3.082015
IMP 0.732491
INR 90.36925
IQD 1309.380459
IRR 42125.000158
ISK 122.749952
JEP 0.732491
JMD 156.640605
JOD 0.709028
JPY 155.879497
KES 129.000415
KGS 87.449822
KHR 4081.504905
KMF 417.999853
KPW 899.987247
KRW 1450.779878
KWD 0.30715
KYD 0.83298
KZT 501.119346
LAK 21499.832523
LBP 89508.041026
LKR 309.380459
LRD 185.911623
LSL 16.009531
LTL 2.95274
LVL 0.60489
LYD 6.319217
MAD 9.168716
MDL 16.926717
MGA 4429.877932
MKD 52.189044
MMK 2100.119929
MNT 3568.429082
MOP 8.04357
MRU 39.901294
MUR 45.890045
MVR 15.450054
MWK 1733.257012
MXN 17.245898
MYR 3.932499
MZN 63.750319
NAD 16.009531
NGN 1391.85959
NIO 36.785781
NOK 9.627875
NPR 144.492309
NZD 1.656195
OMR 0.384498
PAB 0.999521
PEN 3.364907
PGK 4.282347
PHP 59.040236
PKR 279.545138
PLN 3.57644
PYG 6631.277242
QAR 3.634567
RON 4.313702
RSD 99.384049
RUB 76.999691
RWF 1458.783824
SAR 3.750106
SBD 8.058101
SCR 13.748799
SDG 601.49205
SEK 8.90851
SGD 1.270205
SHP 0.750259
SLE 24.475005
SLL 20969.499267
SOS 570.272883
SRD 38.114499
STD 20697.981008
STN 20.775741
SVC 8.746163
SYP 11059.574895
SZL 16.015332
THB 31.639928
TJS 9.340767
TMT 3.51
TND 2.890372
TOP 2.40776
TRY 43.496603
TTD 6.770319
TWD 31.588801
TZS 2584.040204
UAH 43.256279
UGX 3563.251531
UYU 38.49872
UZS 12236.487289
VES 371.640565
VND 26002
VUV 119.537583
WST 2.726316
XAF 556.244594
XAG 0.011767
XAU 0.000201
XCD 2.70255
XCG 1.801384
XDR 0.691072
XOF 556.244594
XPF 101.131218
YER 238.374992
ZAR 15.96902
ZMK 9001.202602
ZMW 19.615608
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • CMSD

    -0.1400

    23.94

    -0.58%

  • CMSC

    -0.0900

    23.66

    -0.38%

  • BCE

    0.2700

    26.1

    +1.03%

  • BCC

    3.1800

    84.93

    +3.74%

  • GSK

    0.8700

    53.34

    +1.63%

  • BTI

    0.8800

    61.87

    +1.42%

  • NGG

    1.6200

    86.23

    +1.88%

  • BP

    1.1200

    38.82

    +2.89%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • RIO

    3.8500

    96.37

    +4%

  • AZN

    -4.0900

    184.32

    -2.22%

  • JRI

    -0.0300

    13.12

    -0.23%

  • RYCEF

    0.2800

    16.95

    +1.65%

  • VOD

    0.3400

    15.25

    +2.23%

  • RELX

    -5.0200

    30.51

    -16.45%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

H.Carroll--TFWP